Market revenue in 2021 | USD 9,531.0 million |
Market revenue in 2028 | USD 14,002.5 million |
Growth rate | 5.6% (CAGR from 2021 to 2028) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & Kits |
Historical data covered | 2016 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & Kits, Analyzers/Instruments, Software & Services |
Key market players worldwide | BioMerieux SA, Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Becton Dickinson & Co, Bio-Rad Laboratories Inc Class A, Beckman Coulter |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay analyzers market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 65.77% in 2021. Horizon Databook has segmented the North America immunoassay analyzers market based on reagents & kits, analyzers/instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America immunoassay analyzers market , including forecasts for subscribers. This continent databook contains high-level insights into North America immunoassay analyzers market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account